QVT Financial LP - Q1 2022 holdings

$2.3 Billion is the total value of QVT Financial LP's 68 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 26.7% .

 Value Shares↓ Weighting
MP SellMP MATERIALS CORP$973,280,000
+11.0%
16,973,834
-12.1%
42.23%
+40.5%
 ROIVANT SCIENCES LTD$639,205,000
-51.0%
129,393,8170.0%27.73%
-38.0%
 WORKDAY INCnote 0.250%10/0$63,722,000
-12.4%
39,000,0000.0%2.76%
+11.0%
 NIO INCnote 4.500% 2/0$45,592,000
-33.0%
20,000,0000.0%1.98%
-15.2%
NewPALO ALTO NETWORKS INCnote 0.750% 7/0$35,199,00015,000,000
+100.0%
1.53%
NXST  NEXSTAR MEDIA GROUP INCcl a$31,238,000
+24.8%
165,7350.0%1.36%
+57.9%
 RHnote 6/1$28,720,000
-38.5%
16,948,0000.0%1.25%
-22.2%
 CARNIVAL CORPnote 5.750% 4/0$26,244,000
-1.6%
12,500,0000.0%1.14%
+24.6%
 MICROSTRATEGY INCnote 0.750%12/1$25,948,000
-10.5%
18,500,0000.0%1.13%
+13.3%
ATEX BuyANTERIX INC$25,862,000
+0.8%
446,666
+2.3%
1.12%
+27.6%
MSTR  MICROSTRATEGY INCput$22,663,000
-10.7%
46,6000.0%0.98%
+13.0%
ILMN BuyILLUMINA INC$18,955,000
+249.7%
54,250
+280.7%
0.82%
+341.9%
 BEST INCnote 1.750%10/0$18,938,000
-0.2%
24,198,0000.0%0.82%
+26.5%
NNI BuyNELNET INCcl a$18,244,000
+8.4%
214,665
+24.6%
0.79%
+37.3%
JOBS  51JOB INCsponsored ads$17,433,000
+19.7%
297,7520.0%0.76%
+51.5%
BRKB  BERKSHIRE HATHAWAY INC DELcl b new$16,921,000
+18.0%
47,9460.0%0.73%
+49.5%
GS BuyGOLDMAN SACHS GROUP INC$15,828,000
+15.8%
47,949
+34.2%
0.69%
+46.5%
NYT  NEW YORK TIMES COcl a$14,529,000
-5.1%
316,9470.0%0.63%
+20.0%
 CLOVIS ONCOLOGY INCnote 4.500% 8/0$14,130,000
-8.2%
20,000,0000.0%0.61%
+16.3%
LILAK  LIBERTY LATIN AMERICA LTD$13,904,000
-15.9%
1,449,8860.0%0.60%
+6.5%
VIAC  PARAMOUNT GLOBAL$13,353,000
+25.3%
353,1650.0%0.58%
+58.6%
MMYT  MAKEMYTRIP LIMITED MAURITIUS$13,173,000
-3.2%
490,9810.0%0.57%
+22.7%
 GDS HLDGS LTDnote 2.000% 6/0$12,677,000
-6.4%
11,500,0000.0%0.55%
+18.5%
BuySEA LTDnote 0.250% 9/1$12,017,000
+8.9%
15,000,000
+25.0%
0.52%
+37.8%
IOVA  IOVANCE BIOTHERAPEUTICS INC$11,298,000
-12.8%
678,5640.0%0.49%
+10.4%
SellQUDIAN INCnote 1.000% 7/0$10,861,000
-28.3%
11,670,000
-30.0%
0.47%
-9.2%
ARGX  ARGENX SEsponsored adr$10,247,000
-10.0%
32,4980.0%0.44%
+14.1%
EURN SellEURONAV NV$9,961,000
-28.6%
942,381
-39.9%
0.43%
-9.6%
 EAGLE BULK SHIPPING INCnote 5.000% 8/0$9,621,000
+37.3%
4,850,0000.0%0.42%
+73.8%
ALLT BuyALLOT LTD$8,933,000
-2.1%
1,102,863
+43.7%
0.39%
+24.0%
HD  HOME DEPOT INC$8,928,000
-27.9%
29,8260.0%0.39%
-8.7%
 STRIDE INCnote 1.125% 9/0$8,065,000
+2.9%
8,000,0000.0%0.35%
+30.1%
BuyBAOZUN INCnote 1.625% 5/0$8,028,000
+70.9%
8,000,000
+60.0%
0.35%
+116.1%
SPY SellSPDR S&P 500 ETF TRtr unit$7,226,000
-74.1%
16,000
-72.8%
0.31%
-67.2%
IMGN  IMMUNOGEN INC$6,549,000
-35.9%
1,375,9000.0%0.28%
-18.9%
NE  NOBLE CORP NEW$6,484,000
+41.3%
185,0000.0%0.28%
+79.0%
NewMAKEMYTRIP LIMITED MAURITIUSnote 2/1$6,455,0006,500,000
+100.0%
0.28%
GTN  GRAY TELEVISION INC$6,432,000
+9.5%
291,4520.0%0.28%
+38.8%
LBTYA  LIBERTY GLOBAL PLC$6,194,000
-8.0%
242,8000.0%0.27%
+16.5%
FRG  FRANCHISE GROUP INC$5,391,000
-20.6%
130,1200.0%0.23%
+0.4%
FSR NewFISKER INC$5,160,000400,000
+100.0%
0.22%
FSR BuyFISKER INCput$5,160,000
+9.3%
400,000
+33.3%
0.22%
+38.3%
NewHUAZHU GROUP LTDnote 0.375%11/0$4,812,0004,780,000
+100.0%
0.21%
FB  META PLATFORMS INCcl a$4,673,000
-33.9%
21,0170.0%0.20%
-16.1%
JD SellJD.COM INCspon adr cl a$3,735,000
-44.7%
64,548
-33.0%
0.16%
-29.9%
VTNR SellVERTEX ENERGY INCput$3,549,000
+40.7%
357,000
-35.9%
0.15%
+79.1%
DHT NewDHT HOLDINGS INC$3,113,000536,650
+100.0%
0.14%
CALM  CAL MAINE FOODS INC$2,961,000
+49.3%
53,6130.0%0.13%
+88.2%
TNK  TEEKAY TANKERS LTDcl a$2,542,000
+27.0%
183,7000.0%0.11%
+59.4%
SNOW NewSNOWFLAKE INCcl a$2,479,00010,820
+100.0%
0.11%
NewIQIYI INCnote 2.000% 4/0$2,385,0003,000,000
+100.0%
0.10%
TCOM NewTRIP COM GROUP LTDads$2,328,000100,705
+100.0%
0.10%
MSTR NewMICROSTRATEGY INCcl a new$2,196,0004,515
+100.0%
0.10%
ACMR BuyACM RESH INC$1,451,000
-27.2%
70,119
+200.0%
0.06%
-7.4%
TIL  INSTIL BIO INC$1,060,000
-37.2%
98,6440.0%0.05%
-20.7%
BABA SellALIBABA GROUP HLDG LTDsponsored ads$1,047,000
-54.4%
9,626
-50.2%
0.04%
-43.0%
CLVS  CLOVIS ONCOLOGY INCput$1,020,000
-25.5%
505,0000.0%0.04%
-6.4%
CLVS NewCLOVIS ONCOLOGY INCcall$1,010,000500,000
+100.0%
0.04%
CLVS  CLOVIS ONCOLOGY INC$1,020,000
-25.5%
505,0000.0%0.04%
-6.4%
 JOYY INCnote 0.750% 6/1$890,000
-2.7%
1,000,0000.0%0.04%
+25.8%
GDS NewGDS HLDGS LTDsponsored ads$695,00017,700
+100.0%
0.03%
BIDU SellBAIDU INCspon adr rep a$688,000
-55.5%
5,200
-50.0%
0.03%
-43.4%
SVSVW NewSPRING VY ACQUISITION CORP*w exp 05/20/202$588,000300,000
+100.0%
0.03%
ACAD  ACADIA PHARMACEUTICALS INC$475,000
+3.7%
19,6130.0%0.02%
+31.2%
APPHW  APPHARVEST INC*w exp 01/30/202$444,000
+51.5%
500,0000.0%0.02%
+90.0%
BMRN  BIOMARIN PHARMACEUTICAL INC$341,000
-12.8%
4,4290.0%0.02%
+15.4%
MRSN  MERSANA THERAPEUTICS INC$250,000
-35.9%
62,6570.0%0.01%
-15.4%
SRPT  SAREPTA THERAPEUTICS INC$244,000
-13.2%
3,1170.0%0.01%
+10.0%
VIPS ExitVIPSHOP HOLDINGS LIMITEDsponsored ads a$0-100,400
-100.0%
-0.03%
SCU ExitSCULPTOR CAP MGMT$0-81,068
-100.0%
-0.06%
VTNR ExitVERTEX ENERGY INC$0-557,000
-100.0%
-0.09%
ILMN ExitILLUMINA INCcall$0-100,000
-100.0%
-1.30%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2022-05-16
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
MAKEMYTRIP LIMITED MAURITIUS38Q3 20236.2%
NEW YORK TIMES CO34Q3 20232.6%
ACCELERON PHARMA INC32Q3 20212.8%
JPMORGAN CHASE & CO32Q3 20212.2%
SAREPTA THERAPEUTICS INC32Q3 20231.1%
BIOMARIN PHARMACEUTICAL INC32Q3 20230.5%
GOLDMAN SACHS GROUP INC30Q3 20235.4%
ACADIA PHARMACEUTICALS INC28Q3 20230.2%
WELLS FARGO CO NEW27Q4 20201.5%
NEXSTAR MEDIA GROUP INC26Q3 20233.4%

View QVT Financial LP's complete holdings history.

Latest significant ownerships (13-D/G)
QVT Financial LP Q1 2022 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
MP Materials Corp. / DEMay 18, 20238,853,7125.0%
Grindrod Shipping Holdings Ltd.Sold outFebruary 14, 202200.0%
AEHR TEST SYSTEMSSold outFebruary 14, 202000.0%
Arbutus Biopharma CorpSold outJuly 12, 201900.0%
Axovant Gene Therapies Ltd.Sold outJuly 12, 201900.0%
Myovant Sciences Ltd.Sold outJuly 12, 201900.0%
Urovant Sciences Ltd.Sold outJuly 12, 201900.0%
Axovant Sciences Ltd.March 19, 2019105,952,38158.2%
Hunter Maritime Acquisition Corp.Sold outFebruary 14, 201900.0%
AGENUS INCFebruary 14, 20183,201,2633.2%

View QVT Financial LP's complete significant-ownership history.

Latest filings
TypeFiled
42024-03-07
SC 13G/A2024-03-07
13F-HR2024-02-14
SC 13G/A2024-02-14
13F-HR2023-11-14
42023-10-02
1442023-09-28
13F-HR2023-08-14
SC 13D/A2023-05-18
13F-HR2023-05-15

View QVT Financial LP's complete filings history.

Compare quarters

Export QVT Financial LP's holdings